Maria Grazia Ghi

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari et al. · Annals of Oncology · 2017 · 204 citations

Medicine, Oncology, Radiation Oncology +15

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

P. L. Zorat, A. Paccagnella, G Cavaniglia et al. · JNCI Journal of the National Cancer Institute · 2004 · 187 citations · Full text

Medicine, Oncology, Cancer Control +10

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian et al. · Annals of Oncology · 2009 · 187 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon et al. · The Lancet Oncology · 2021 · 107 citations · Full text

Medicine, Oncology, Radiation Oncology +16